European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision
暂无分享,去创建一个
P. Bergh | J. M. | J. Pollard | C. Sommer | C. Koski | M. Suárez-Calvet | I. Illa | D. Cornblath | R. Hadden | P. Doorn | E. Nobile‐Orazio | J. Léger | I. V. Schaik | P. J. | C. A. | Sommer C | Marina De | I. N. Schaik | Van Doorn | P. V. D. Bergh | Van Den | S. Hernandez | Texido L | Caldero J | Ciutat D | Piedrafita L | Casanovas A | Blasi J | Solsona C | Povedano M | R. R | Illa I | Caress J | P. D. | Oppenheim R W | Milligan C | Esquerda J E | Van Schaik | I. N. Leger | J.-M | Nobile-Orazio E | Cornblath D R | Hadden R D M | Koski C L | Bergh P | P. A. European | Paradas C | Llauger J Diaz-Manera | Luna N | Iturriaga C | M. C | Uson M | Hankiewicz K | Gallardo E | Illa I Redefining | Skeie G O | Apostolski S | Evoli A | Gilhus N E | Harms L | Hilton-Jones D | Melms A | Verschuuren J | Horge H W | J. C. | Martinez-Hernandez E | Casasnovas C | Fages E Davila-Gonzalez | Illa I Bulbar | Luna N De | Sonnet C | C. B | D. R. | Suarez-Calvet X | Gherardi R K | Bergh P Y K | Bouche P | H. A | I. European | Giannoni E Diaz-Manera | Parri M | Cossu G | Chiarugi P | Q. L | Sarmiento L M | Domingo P | Martinez-Ramirez S | Alcolea D | Marquie M | Marti-Vilalta J L | Marti-Fabregas J Remote | I. Illa | C. L. Koski | John D. Pollard | C. Sommer | Pieter A. Doorn | Eduardo Nobile‐Orazio | J. Léger
[1] Belgium,et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision , 2010, Journal of the peripheral nervous system : JPNS.
[2] D. Cocito,et al. Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy , 2009, Journal of the peripheral nervous system : JPNS.
[3] F. Aichner,et al. Beneficial effect of rituximab monotherapy in multifocal motor neuropathy , 2009, Neuromuscular Disorders.
[4] L. H. van den Berg,et al. Subcutaneous immunoglobulin therapy for multifocal motor neuropathy , 2009, Journal of the peripheral nervous system : JPNS.
[5] J. Jakobsen,et al. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single‐blinded cross‐over trial , 2009, European journal of neurology.
[6] C. Hess,et al. IVIg dose increase in multifocal motor neuropathy , 2009, Journal of Neurology.
[7] T. Maisonobe,et al. Neuropathie motrice multifocale : existe-t-il une altération de la conduction sensitive au long cours ? Une étude rétrospective chez 21 patients , 2009 .
[8] V. Lambrecq,et al. Sensory loss in multifocal motor neuropathy: A clinical and electrophysiological study , 2009, Muscle & nerve.
[9] H. Hartung,et al. The clinical value of therapeutic plasma exchange in multifocal motor neuropathy , 2008, Journal of the Neurological Sciences.
[10] T. Maisonobe,et al. Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[11] L. H. van den Berg,et al. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. , 2007, Brain : a journal of neurology.
[12] R. Weinstein,et al. Rituximab treatment in patients with IVIg‐dependent immune polyneuropathy: A prospective pilot trial , 2007, Muscle & nerve.
[13] M. Slee,et al. Multifocal motor neuropathy , 2007, Neurology.
[14] L. H. van den Berg,et al. Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve. , 2006, Brain : a journal of neurology.
[15] J. Pouget,et al. Multifocal motor neuropathy with and without conduction block , 2006, Neurology.
[16] K. Nakamura,et al. Activity-dependent conduction block in multifocal motor neuropathy. , 2000, Brain : a journal of neurology.
[17] C. Polman,et al. Axon loss is an important determinant of weakness in multifocal motor neuropathy , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[18] A. Priori,et al. Multifocal motor neuropathy: Current concepts and controversies , 2005, Muscle & nerve.
[19] G. Zenebe,et al. Neurologic services in the nations of Africa , 2005, Neurology.
[20] P. Fuhr,et al. Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg , 2004, Neurology.
[21] S. Vucic,et al. Multifocal motor neuropathy , 2004, Neurology.
[22] S. Barbieri,et al. How long is IVIg effective in multifocal motor neuropathy? , 2004, Neurology.
[23] R. Rojas-García,et al. Chronic neuropathy with IgM anti-ganglioside antibodies: Lack of long term response to rituximab , 2003, Neurology.
[24] K. Oshimi,et al. Multifocal motor neuropathy caused by a B‐cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b , 2003, British journal of haematology.
[25] E. Calabrese,et al. Efficacy of cyclosporine treatment in multifocal motor neuropathy , 2003, Journal of Neurology.
[26] Ryuji Kaji,et al. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies , 2003, Muscle & nerve.
[27] R. Lewis,et al. Consensus criteria for the diagnosis of multifocal motor neuropathy , 2003, Muscle & nerve.
[28] L. H. van den Berg,et al. Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. , 2003, Brain : a journal of neurology.
[29] H. Willison,et al. Peripheral neuropathies and anti-glycolipid antibodies. , 2002, Brain : a journal of neurology.
[30] F. Trimarchi,et al. Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association , 2002, Neuromuscular Disorders.
[31] R. Schwartzman,et al. High-dose cyclophosphamide without stem-cell rescue for refractory CIDP , 2002, Neurology.
[32] L. H. van den Berg,et al. Mimic syndromes in sporadic cases of progressive spinal muscular atrophy , 2002, Neurology.
[33] E. Nobile‐Orazio. Multifocal motor neuropathy , 2001, Journal of Neuroimmunology.
[34] P. R. A. C. Hughes,et al. 79th ENMC International Workshop: Multifocal motor neuropathy 14–15 April 2000, Hilversum, The Netherlands , 2001, Neuromuscular Disorders.
[35] V. Meininger,et al. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. , 2001, Brain : a journal of neurology.
[36] L. H. van den Berg,et al. Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment , 2000, Annals of neurology.
[37] W. Brown,et al. Multifocal motor neuropathy improved by IVIg , 2000, Neurology.
[38] P. Dyck,et al. Natural history of 46 patients with multifocal motor neuropathy with conduction block , 2000, Muscle & nerve.
[39] L. H. van den Berg,et al. Treatment of multifocal motor neuropathy with interferon-β1A , 2000, Neurology.
[40] D. Claus,et al. Plasmapheresis in multifocal motor neuropathy: a case report , 2000, Journal of neurology, neurosurgery, and psychiatry.
[41] G. Jansen,et al. Multifocal inflammatory demyelinating neuropathy , 2000, Neurology.
[42] R. Lewis. Multifocal motor neuropathy and Lewis Sumner syndrome: Two distinct entities , 1999, Muscle & nerve.
[43] J. Kimura,et al. Multifocal motor neuropathy and Lewis Sumner syndrome: A clinical spectrum , 1999, Muscle & nerve.
[44] J. Molinuevo,et al. Central motor conduction time in patients with multifocal motor conduction block , 1999, Muscle & nerve.
[45] C. Shaw,et al. Use of human intravenous immunoglobulin in lower motor neuron syndromes , 1999, Journal of neurology, neurosurgery, and psychiatry.
[46] D. Burns,et al. Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis–Sumner syndrome , 1999, Muscle & nerve.
[47] G. Parry. Are multifocal motor neuropathy and Lewis–Sumner syndrome distinct nosologic entities? , 1999, Muscle & nerve.
[48] J. Meulstee,et al. Chronic motor neuropathies: response to interferon-β1a after failure of conventional therapies , 1999, Journal of neurology, neurosurgery, and psychiatry.
[49] S. Beydoun,et al. Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies , 1998, Muscle & nerve.
[50] S. Barbieri,et al. Deterioration of multifocal motor neuropathy after plasma exchange , 1998, Neurology.
[51] L. H. van den Berg,et al. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. , 1998, Brain : a journal of neurology.
[52] G. Parry,et al. Multifocal motor neuropathy without overt conduction block , 1998, Muscle & nerve.
[53] S. Barbieri,et al. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy , 1997, Journal of neurology, neurosurgery, and psychiatry.
[54] L. H. van den Berg,et al. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy , 1997, Neurology.
[55] L. H. van den Berg,et al. Pulsed high‐dose dexamethasone is not effective in patients with multifocal motor neuropathy , 1997, Neurology.
[56] O. Blin,et al. Long term follow up of multifocal motor neuropathy with conduction block under treatment. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[57] D. S. Kim,et al. Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy? , 1997, Journal of the peripheral nervous system : JPNS.
[58] A. Windebank,et al. The sensitivity and specificity of anti-GM sub 1 antibody testing , 1996, Neurology.
[59] T. Crawford,et al. Sensory nerve pathology in multifocal motor neuropathy , 1996, Annals of neurology.
[60] W. Robberecht,et al. Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block , 1996, Journal of the Neurological Sciences.
[61] L. H. van den Berg,et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[62] A. Brand,et al. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies , 1995, Neurology.
[63] V. Meininger,et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[64] O. Blin,et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti‐GM1 antibodies , 1994, Neurology.
[65] G. Parry,et al. Motor Neuropathy with Multifocal Conduction Block , 1993, Seminars in neurology.
[66] Robert G. Miller,et al. Multifocal motor neuropathy: Response to human immune globulin , 1993 .
[67] A. Pestronk,et al. Immunosuppressive treatment in multifocal motor neuropathy , 1991, Annals of neurology.
[68] W. Brown,et al. Conduction block in clinical practice , 1991, Muscle & nerve.
[69] I. Hausmanowa-Petrusewicz,et al. Chronic acquired demyelinating motor neuropathy , 1991, Acta neurologica Scandinavica.
[70] J. England,et al. A computer simulation of conduction block: Effects produced by actual block versus interphase cancellation , 1990, Annals of neurology.
[71] A. Pestronk,et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies , 1990, Annals of neurology.
[72] S. Lipton,et al. A syndrome of asymmetric limb weakness with motor conduction block , 1990, Neurology.
[73] A. Pestronk,et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside , 1988, Annals of neurology.
[74] G. Parry,et al. Multifocal acquired demyelinating neuropathy masqurading as motor neuron disease , 1988, Muscle & nerve.
[75] D. Chad,et al. Slow resolution of multifocal weakness and fasciculation , 1986, Neurology.
[76] M. Magistris,et al. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. , 1986, European neurology.